PMID: 7547249Oct 1, 1995Paper

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer

British Journal of Cancer
E M BernsJ A Foekens

Abstract

Changes which lead to excessive cyclin production or to loss of cell cycle inhibition by proteins such as p16/MTS1 may release breast tumour cells from the constraints of cell division. In order to establish the frequency of MTS1/p16 gene alteration and its relation with genetic damage to the p53 and cyclin D1 genes, we have studied these gene abnormalities in 164 human primary breast cancers and in six breast cancer cell lines. Two breast cancer cell lines and one primary tumour showed a homozygous deletion of exon 2 of the MTS1 gene. Using single-strand conformation polymorphism and subsequent sequencing analysis, one tumour showed an alteration at codon 67 (CCC-->CTC; Pro to Leu). Another tumour showed a mutation at codon 98 (without amino acid change) with an additional polymorphism at codon 140. This polymorphism was also found in 13 other tumour samples, but has no effect on (disease-free) survival. From these data we conclude that the occurrence of CDKN2 (p16/MTS1) mutation in primary breast cancer is a rare event and is not likely to be involved in human breast tumour carcinogenesis and progression.

Citations

Oct 1, 1996·Leukemia & Lymphoma·M Heyman, S Einhorn
Aug 1, 1997·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·G Landberg, G Roos
Feb 4, 2010·The Journal of Cell Biology·Sarah L Thompson, Duane A Compton
Jul 25, 2018·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Ayesha AftabSobia Tabassum
Jun 25, 2019·Genes & Genetic Systems·Ranjha KhanIhtisham Bukhari
Aug 24, 2001·Breast Cancer Research and Treatment·K Milde-LangoschT Löning
Jan 1, 1996·Human Mutation·B Smith-Sørensen, E Hovig
Nov 21, 1998·Biochimica Et Biophysica Acta·M Ruas, G Peters
Oct 17, 2002·Seminars in Radiation Oncology·Deborah A Dillon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.